How to assess kidney function in oncology patients
Assessment of kidney function in oncology patients is a fundamental factor in profiling the survival risk, determining the appropriate dose of chemotherapeutic drugs and defining a patient eligibility for clinical trials with novel agents. Both overestimation and underestimation of kidney function may affect the treatment efficacy and outcomes. Overestimation may lead to overdosing or inappropriate agent selection and corresponding toxicity, while underestimation may be responsible for underdosing or inappropriate agent exclusion and subsequent treatment failure.
Source: Kidney International - Category: Urology & Nephrology Authors: Jolanta Malyszko, Michael W. Lee, Giovambattista Capasso, Pawel Kulicki, Joanna Matuszkiewicz-Rowinska, Pierre Ronco, Paul Stevens, Petra Tesarova, Davide Viggiano, Anna Capasso Tags: Review Source Type: research